Runda Medical's major shareholders to significantly reduce stakes

Shanghai Runda Medical Technology announced that its major shareholders, Zhu Wenyi and Liu Hui, plan to reduce their respective shareholdings. Zhu Wenyi intends to divest up to 10.54 million shares, representing 1.75% of the company's total share capital. Concurrently, Liu Hui, a director and senior manager, plans to sell up to 7.46 million shares, equivalent to 1.24% of the total share capital.

The share reduction will occur over three months, commencing 15 trading days after October 30, 2025, and concluding on January 29, 2026. Both shareholders will utilize a combination of centralized bidding and block trading methods. Zhu Wenyi's shares were acquired pre-IPO, while Liu Hui's holdings comprise pre-IPO, non-public issuance, and centralized bidding acquisitions. The stated reason for both reductions is personal financial needs.

Collectively, Zhu Wenyi and Liu Hui, who are related as mother and son, hold 63.05 million shares, accounting for 10.44% of the company's total shares. The company has clarified that this planned reduction will not lead to a change in company control.